November 25, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: covid

3 min read

The COVID-19 pandemic is tearing through the country right as we are starting into the holiday season, but the wheels of science including cell biology keep going and we keep reading all the great work. What news or papers caught your eye? Here are some of the things I have on my list of reading. Also, check out our most-read topic here on The Niche of the last month or so in two posts here and here digging into what I see as Duke’s cord …Read More

4 min read

I’m not a virologist, but I’m still getting asked these days about what the risks might be from the new generation of RNA vaccines for COVID-19. Approaching this question instead as a biologist and genetics/genomics researcher, I can see a handful of at least hypothetical risks. Below I discuss these possible risks and why I’m generally not so concerned. Barring some new worrisome data, I’m planning to get a COVID-19 vaccine when the time comes that it’s available to me. The early data suggests …Read More

3 min read

There have been many other interesting scientific and specifically regenerative medicine developments and papers this past week including with CIRM and exciting CIRM funding to UC Davis so read on, but first a somewhat random question: are you more of a cat person or dog person? I’d say I’m both. But our big dog is not a fan of cats so I have to get my random cat time in on walks if I happen to run into a cat. I crossed paths with …Read More

3 min read

As a researcher, is there ever enough time to get to everything that you want to read especially in newer areas like stem cells, organoids, and CRISPR, without even including non-scientific reads like Shakespeare or a new novel or something like that? Hopefully, putting together lists of recommended reads like today’s post is helpful. I wonder what Shakespeare would have thought about organoids? Media including COVID-19 updates Interesting change at Nature, which will be diving more into political coverage. Here’s their editorial on this …Read More